홈 > 시장보고서 > 의료기기 > 신경질환

시장보고서

상품코드

1697924

세계의 신경가소성 강화 기기 시장 규모, 점유율, 동향, 업계 분석 : 제품 유형별, 용도별, 최종사용자별, 지역별 - 시장 예측(2025-2034년)

Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type, Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

발행일: 2025년 03월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 129 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최신 조사에 따르면 세계의 신경가소성 강화 기기 시장 규모는 2034년까지 714억 달러에 달할 전망입니다. 이 조사 리포트는 현재 시장 역학의 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.

신경가소성은 새로운 신경 연결을 형성하여 스스로를 재구성하는 뇌의 능력으로, 신경과학, 인지과학, 의학 연구의 주요 초점이 되고 있습니다. 최근 기술의 발전으로 뇌 기능을 최적화하고, 학습을 촉진하고, 재활을 돕고, 자연적 한계를 넘어 인지 능력을 향상시키는 것을 목표로 하는 신경가소성 강화 기기가 개발되고 있습니다. 이러한 장비들은 신경가소성의 변화를 촉진하기 위해 전기 자극, 자기 자극, 뇌파 변조, 뉴로피드백, 감각 강화 등 다양한 기술을 사용합니다.

경두개 자기 자극(TMS)은 자기장을 이용하여 뇌에 전류를 유도하여 신경의 재구성을 촉진하는 널리 사용되는 장비로, 우울증 치료제로 승인되었으며, 파킨슨병, 만성 통증 등 다른 신경질환의 치료에도 효과가 있는 것으로 나타났습니다.

이러한 장비를 통해 사용자는 자신의 뇌 활동을 실시간으로 모니터링하고 조정할 수 있습니다. 뇌파(EEG) 기반 신경 피드백 장비는 뇌파 패턴을 추적하고 시각, 청각 또는 촉각 신호를 통해 피드백을 제공하여 사용자가 원하는 상태로 뇌 활동을 훈련할 수 있도록 도와줍니다. 뇌-컴퓨터 인터페이스(BCI)도 신경 가소성 강화에 중요한 역할을 하고 있으며, 특히 마비나 신경 퇴행성 질환을 앓고 있는 사람들에게 큰 변화를 가져와 기능적 독립성을 되찾을 수 있도록 돕고 있습니다.

신경가소성 강화 기기 시장 : 분석 개요

제품 유형별로는 경두개 자기자극(TMS) 기기 부문이 신경질환 및 정신질환 치료에 효과가 입증되면서 2024년 신경가소성 강화 기기 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.

최종사용자별로 보면 인지 기능 향상 및 신경학적 재활을 위해 개인이 편리하고 비용 효율적인 솔루션을 찾고 있으므로 홈헬스케어 부문이 향후 수년간 지배적인 점유율을 차지할 것으로 예상됩니다.

북미는 강력한 의료 인프라, 첨단 신경기술의 높은 채택률, 신경질환 유병률 증가로 인해 2024년 세계 신경가소성 강화 기기 시장의 매출 점유율을 독식할 것으로 예상됩니다.

아시아태평양 시장은 급속한 도시화, 의료비 지출 증가, 뇌에 대한 인식 증가로 인해 향후 수년간 성장할 것으로 예상됩니다.

세계 주요 기업의 일례로서 BioSerenity, Blackrock Neurotech, BrainCo, BrainsWay, Ceribell, EMOTIV, Flow Neuroscience, Neurable, Neuralink, NeuroPace, Paradromics, Synchron 등을 들 수 있습니다.

시장 스냅숏
신경가소성 강화 기기 시장 역학
- 촉진요인과 기회
  - 세계의 고령화 인구의 증가
  - 젊은층에서 우울증의 유병률 증가
- 억제요인과 과제
  - 고액의 비용과 낮은 인지도
PESTLE 분석
신경가소성 강화 기기 시장 동향
밸류체인 분석
COVID-19의 영향 분석

제5장 세계의 신경가소성 강화 기기 시장 : 제품 유형별

주요 조사 결과
서론
경두개 자기 자극(TMS) 기기
경두개 직류 전류 자극(tDCS) 기기
뇌파(EEG) 기반 기기
기타

제6장 세계의 신경가소성 강화 기기 시장 : 용도별

주요 조사 결과
서론
인지 능력의 향상
뇌졸중·외상성 뇌손상으로부터 회복
정신건강·신경질환
학습·기억 개선
기타

제7장 세계의 신경가소성 강화 기기 시장 : 최종사용자별

주요 조사 결과
서론
병원·진료소
연구기관·학술 센터
재택 의료
기타

제8장 세계의 신경가소성 강화 기기 시장 : 지역별

주요 조사 결과
서론
- 신경가소성 강화 기기 시장 분석 : 지역별(2020-2034년)
북미
- 북미 : 제품 유형별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종사용자별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 제품 유형별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종사용자별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 제품 유형별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종사용자별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 제품 유형별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종사용자별(2020-2034년)
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 제품 유형별, 2020-2034년
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종사용자별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제9장 경쟁 구도

사업 확대·기업 인수 분석
- 사업 확대
- 기업 인수
제휴/협업/합의/공개

제10장 기업 개요

BioSerenity
Blackrock Neurotech
BrainCo Inc.
BrainsWay
Ceribell, Inc.
EMOTIV
Flow Neuroscience
Neurable
Neuralink
NeuroPace, Inc.
Paradromics
Synchron

KSA 25.05.02

The global neuroplasticity enhancement devices market size is expected to reach USD 71.40 billion by 2034, according to a new study by Polaris Market Research. The report "Neuroplasticity Enhancement Devices Market Size, Share, Trends, Industry Analysis Report: By Product Type [Transcranial Magnetic Stimulation (TMS) Devices, Transcranial Direct Current Stimulation (tDCS) Devices, Electroencephalogram (EEG)-Based Devices, and Others], Application, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Neuroplasticity, the brain's ability to reorganize itself by forming new neural connections, has been a major focus in neuroscience, cognitive science, and medical research. In recent years, advancements in technology have led to the development of neuroplasticity enhancement devices, which aim to optimize brain function, accelerate learning, aid in rehabilitation, and even enhance cognitive abilities beyond natural limits. These devices use a variety of techniques, including electrical and magnetic stimulation, brainwave modulation, neurofeedback, and sensory augmentation, to encourage neuroplastic changes.

Transcranial magnetic stimulation (TMS) is a widely used device that employs magnetic fields to induce electric currents in the brain, facilitating neural reorganization. TMS has been approved for treating depression and has shown effectiveness in treating other neurological disorders, such as Parkinson's disease and chronic pain conditions.

These device allow users to monitor and regulate their brain activity in real time, providing a form of self-directed neuroplasticity training. Electroencephalography (EEG)-based neurofeedback devices track brainwave patterns and provide feedback through visual, auditory, or haptic cues, helping users train their brain activity toward desired states. Brain-computer interfaces (BCIs) are also playing a crucial role in neuroplasticity enhancement. BCIs have been particularly transformative for individuals affected by paralysis or neurodegenerative conditions, enabling them to regain functional independence.

Neuroplasticity Enhancement Devices Market Report Highlights

In terms of product type, the transcranial magnetic stimulation (TMS) devices segment held the largest neuroplasticity enhancement devices market share in 2024 due to their proven effectiveness in treating neurological and psychiatric disorders.

Based on end user, the home care settings segment is projected to hold a dominant share in the coming years as individuals seek convenient, cost-effective solutions for cognitive enhancement and neurological rehabilitation.

North America dominated the global neuroplasticity enhancement devices market revenue share in 2024 due to its strong healthcare infrastructure, high adoption of advanced neurotechnology, and increasing prevalence of neurological disorders.

The market in Asia Pacific is expected to grow in the coming years, owing to rapid urbanization, increasing healthcare expenditures, and growing awareness of the brain.

A few of the global key market players are BioSerenity; Blackrock Neurotech; BrainCo Inc.; BrainsWay; Ceribell, Inc.; EMOTIV; Flow Neuroscience; Neurable; Neuralink; NeuroPace, Inc.; Paradromics; and Synchron.

Polaris Market Research has segmented the neuroplasticity enhancement devices market report on the basis of product type, application, end user, and region:

By Product Type Outlook (Revenue, USD Billion, 2020-2034)

Transcranial Magnetic Stimulation (TMS) Devices
Transcranial Direct Current Stimulation (tDCS) Devices
Electroencephalogram (EEG)-Based Devices
Others

By Application Mode Outlook (Revenue, USD Billion, 2020-2034)

Cognitive Enhancement
Stroke & Traumatic Brain Injury Recovery
Mental Health & Neurological Disorders
Learning & Memory Improvement
Others

By End User Outlook (Revenue, USD Billion, 2020-2034)

Hospitals & Clinics
Research Institutions & Academic Centers
Home Care Settings
Others

By Regional Outlook (Revenue, USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Neuroplasticity Enhancement Devices Market Insights

4.1. Neuroplasticity Enhancement Devices Market - Market Snapshot
4.2. Neuroplasticity Enhancement Devices Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Geriatric Population Globally
  - 4.2.1.2. Growing Prevalence of Depression Among Young Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost and lack of awareness
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Neuroplasticity Enhancement Devices Market Trends
4.6. Value Chain Analysis

5. Global Neuroplasticity Enhancement Devices Market, by Product Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
5.3. Transcranial Magnetic Stimulation (TMS) Devices
- 5.3.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Magnetic Stimulation (TMS) Devices, by Region, 2020-2034 (USD Billion)
5.4. Transcranial Direct Current Stimulation (tDCS) Devices
- 5.4.1. Global Neuroplasticity Enhancement Devices Market, by Transcranial Direct Current Stimulation (tDCS) Devices, by Region, 2020-2034 (USD Billion)
5.5. Electroencephalogram (EEG)-Based Devices
- 5.5.1. Global Neuroplasticity Enhancement Devices Market, by Electroencephalogram (EEG)-Based Devices, by Region, 2020-2034 (USD Billion)
5.6. Others
- 5.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Neuroplasticity Enhancement Devices Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
6.3. Cognitive Enhancement
- 6.3.1. Global Neuroplasticity Enhancement Devices Market, by Cognitive Enhancement, by Region, 2020-2034 (USD Billion)
6.4. Stroke & Traumatic Brain Injury Recovery
- 6.4.1. Global Neuroplasticity Enhancement Devices Market, by Stroke & Traumatic Brain Injury Recovery, by Region, 2020-2034 (USD Billion)
6.5. Mental Health & Neurological Disorders
- 6.5.1. Global Neuroplasticity Enhancement Devices Market, by Mental Health & Neurological Disorders, by Region, 2020-2034 (USD Billion)
6.6. Learning & Memory Improvement
- 6.6.1. Global Neuroplasticity Enhancement Devices Market, by Learning & Memory Improvement, by Region, 2020-2034 (USD Billion)
6.7. Others
- 6.7.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Neuroplasticity Enhancement Devices Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
7.3. Hospitals & Clinics
- 7.3.1. Global Neuroplasticity Enhancement Devices Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
7.4. Research Institutions & Academic Centers
- 7.4.1. Global Neuroplasticity Enhancement Devices Market, by Research Institutions & Academic Centers, by Region, 2020-2034 (USD Billion)
7.5. Home Care Settings
- 7.5.1. Global Neuroplasticity Enhancement Devices Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)
7.6. Others
- 7.6.1. Global Neuroplasticity Enhancement Devices Market, by Others, by Region, 2020-2034 (USD Billion)

8. Global Neuroplasticity Enhancement Devices Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Neuroplasticity Enhancement Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Neuroplasticity Enhancement Devices Market - North America
- 8.3.1. North America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.3.2. North America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.3.3. North America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Neuroplasticity Enhancement Devices Market - U.S.
  - 8.3.4.1. U.S.: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Neuroplasticity Enhancement Devices Market - Canada
  - 8.3.5.1. Canada: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.4. Neuroplasticity Enhancement Devices Market - Europe
- 8.4.1. Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.4.2. Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.4.3. Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Neuroplasticity Enhancement Devices Market - UK
  - 8.4.4.1. UK: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Neuroplasticity Enhancement Devices Market - France
  - 8.4.5.1. France: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Neuroplasticity Enhancement Devices Market - Germany
  - 8.4.6.1. Germany: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Neuroplasticity Enhancement Devices Market - Italy
  - 8.4.7.1. Italy: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Neuroplasticity Enhancement Devices Market - Spain
  - 8.4.8.1. Spain: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Neuroplasticity Enhancement Devices Market - Netherlands
  - 8.4.9.1. Netherlands: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Neuroplasticity Enhancement Devices Market - Russia
  - 8.4.10.1. Russia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Neuroplasticity Enhancement Devices Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.5. Neuroplasticity Enhancement Devices Market - Asia Pacific
- 8.5.1. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Neuroplasticity Enhancement Devices Market - China
  - 8.5.4.1. China: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Neuroplasticity Enhancement Devices Market - India
  - 8.5.5.1. India: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Neuroplasticity Enhancement Devices Market - Malaysia
  - 8.5.6.1. Malaysia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Neuroplasticity Enhancement Devices Market - Japan
  - 8.5.7.1. Japan: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Neuroplasticity Enhancement Devices Market - Indonesia
  - 8.5.8.1. Indonesia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Neuroplasticity Enhancement Devices Market - South Korea
  - 8.5.9.1. South Korea: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Neuroplasticity Enhancement Devices Market - Australia
  - 8.5.10.1. Australia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Neuroplasticity Enhancement Devices Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.6. Neuroplasticity Enhancement Devices Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Neuroplasticity Enhancement Devices Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Neuroplasticity Enhancement Devices Market - UAE
  - 8.6.5.1. UAE: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Neuroplasticity Enhancement Devices Market - Israel
  - 8.6.6.1. Israel: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Neuroplasticity Enhancement Devices Market - South Africa
  - 8.6.7.1. South Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Neuroplasticity Enhancement Devices Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
8.7. Neuroplasticity Enhancement Devices Market - Latin America
- 8.7.1. Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Neuroplasticity Enhancement Devices Market - Mexico
  - 8.7.4.1. Mexico: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Neuroplasticity Enhancement Devices Market - Brazil
  - 8.7.5.1. Brazil: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Neuroplasticity Enhancement Devices Market - Argentina
  - 8.7.6.1. Argentina: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Neuroplasticity Enhancement Devices Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Product Type, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by Application, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Neuroplasticity Enhancement Devices Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. BioSerenity
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Blackrock Neurotech
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. BrainCo Inc.
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. BrainsWay
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Ceribell, Inc.
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. EMOTIV
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Flow Neuroscience
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Neurable
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Neuralink
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. NeuroPace, Inc.
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Paradromics
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Synchron
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,250

￦ 6,086,000

PDF (Multi User License)

PDF 보고서를 동일 기업 20명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,250

￦ 7,519,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,250

￦ 8,951,000

※ 부가세 별도

검색

F A Q